miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met (Q38886375)

25880599

7 September 2017

title

miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met (English)

1 reference

7 September 2017

Guangfeng Niu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496886&resulttype=core&format=json

14 May 2020

Bin Li

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496886&resulttype=core&format=json

14 May 2020

Jianmin Sun

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496886&resulttype=core&format=json

14 May 2020

Li Sun

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496886&resulttype=core&format=json

14 May 2020

language of work or name

1 reference

16 April 2015

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496886&resulttype=core&format=json

14 May 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496886&resulttype=core&format=json

14 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496886&resulttype=core&format=json

14 May 2020

page(s)

348-355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496886&resulttype=core&format=json

Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma

14 May 2020

cites work

1 reference

Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells.

21 January 2018

1 reference

Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition

21 January 2018

1 reference

Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines

21 January 2018

1 reference

MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma

21 January 2018

1 reference

Propofol inhibits proliferation and invasion of osteosarcoma cells by regulation of microRNA-143 expression

21 January 2018

1 reference

C-Myc overexpression promotes osteosarcoma cell invasion via activation of MEK-ERK pathway

21 January 2018

1 reference

MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro

21 January 2018

1 reference

MicroRNA-200c inhibits apoptosis in pituitary adenoma cells by targeting the PTEN/Akt signaling pathway

21 January 2018

1 reference

MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.

21 January 2018

1 reference

Histone deacetylases and NF-kB signaling coordinate expression of CX3CL1 in epithelial cells in response to microbial challenge by suppressing miR-424 and miR-503.

21 January 2018

1 reference

Sp1-mediated microRNA-182 expression regulates lung cancer progression.

21 January 2018

1 reference

Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression

21 January 2018

1 reference

MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus

21 January 2018

1 reference

MicroRNA-217 promotes angiogenesis of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and FOXO3A.

21 January 2018

1 reference

MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.

21 January 2018

1 reference

MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells

21 January 2018

1 reference

miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1.

21 January 2018

1 reference

In-depth analysis shows synergy between erlotinib and miR-34a

21 January 2018

1 reference

MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo

21 January 2018

1 reference

Modulation of the osteosarcoma expression phenotype by microRNAs

21 January 2018

1 reference

The miRNAs in the pathgenesis of osteosarcoma

21 January 2018

1 reference

miRNA signatures associate with pathogenesis and progression of osteosarcoma

21 January 2018

1 reference

MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.

21 January 2018

1 reference

miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.

21 January 2018

1 reference

The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression

21 January 2018

1 reference

Expression of microRNA-454 in TGF-β1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum

21 January 2018

1 reference

Plasma microRNAs as biomarkers for myotonic dystrophy type 1.

21 January 2018

1 reference

Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma

21 January 2018

1 reference

Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migration

21 January 2018

1 reference

MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas

21 January 2018

1 reference

Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models

21 January 2018

1 reference

c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutation

21 January 2018

1 reference

Involvement of MET/TWIST/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesis

21 January 2018

1 reference

Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling

21 January 2018

1 reference

c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells

21 January 2018

1 reference

met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.

21 January 2018

1 reference

MET oncogene aberrant expression in canine osteosarcoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25880599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Screening for metastatic osteosarcoma biomarkers with a DNA microarray

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25880599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25880599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/CPR.12187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496886&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496886&resulttype=core&format=json

14 May 2020

25880599

1 reference